1 序文
2 調査範囲と方法論
2.1 調査の目的
2.2 ステークホルダー
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップ・アプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法
3 エグゼクティブ・サマリー
4 はじめに
4.1 概要
4.2 主要業界動向
5 幹細胞バンキングの世界市場
5.1 市場概要
5.2 市場パフォーマンス
5.3 COVID-19の影響
5.4 製品タイプ別市場構成
5.5 サービスタイプ別市場構成
5.6 銀行タイプ別市場構成比
5.7 利用形態別市場構成比
5.8 用途別市場構成比
5.9 地域別市場構成比
5.10 市場予測
6 製品タイプ別市場構成
6.1 成人幹細胞
6.1.1 市場動向
6.1.2 市場予測
6.2 ヒト胚性幹細胞
6.2.1 市場動向
6.2.2 市場予測
6.3 IPS細胞
6.3.1 市場動向
6.3.2 市場予測
7 サービスタイプ別市場
7.1 サンプル保存・保管
7.1.1 市場動向
7.1.2 市場予測
7.2 サンプル分析
7.2.1 市場動向
7.2.2 市場予測
7.3 サンプル加工
7.3.1 市場動向
7.3.2 市場予測
7.4 サンプル採取と輸送
7.4.1 市場動向
7.4.2 市場予測
8 銀行タイプ別市場内訳
8.1 プライベート
8.1.1 市場動向
8.1.2 市場予測
8.2 パブリック
8.2.1 市場動向
8.2.2 市場予測
9 用途別市場
9.1 中古
9.1.1 市場動向
9.1.2 市場予測
9.2 未使用
9.2.1 市場動向
9.2.2 市場予測
10 アプリケーション別市場
10.1 パーソナライズド・バンキングの用途
10.1.1 市場動向
10.1.2 市場予測
10.2 リサーチ用途
10.2.1 市場動向
10.2.2 市場予測
10.3 臨床アプリケーション
10.3.1 市場動向
10.3.2 市場予測
11 地域別市場内訳
11.1 北米
11.1.1 市場動向
11.1.2 市場予測
11.2 欧州
11.2.1 市場動向
11.2.2 市場予測
11.3 アジア太平洋
11.3.1 市場動向
11.3.2 市場予測
11.4 中東・アフリカ
11.4.1 市場動向
11.4.2 市場予測
11.5 中南米
11.5.1 市場動向
11.5.2 市場予測
12 世界の幹細胞バンキング産業SWOT分析
12.1 概要
12.2 強み
12.3 弱点
12.4 機会
12.5 脅威
13 世界の幹細胞バンキング産業：バリューチェーン分析
14 世界の幹細胞バンキング産業：バリューチェーン分析ポーターズファイブフォース分析
14.1 概要
14.2 買い手の交渉力
14.3 供給者の交渉力
14.4 競争の程度
14.5 新規参入の脅威
14.6 代替品の脅威
15 世界の幹細胞バンキング産業：価格分析
16 競争環境
16.1 市場構造
16.2 主要プレイヤー
16.3 主要プレーヤーのプロフィール
16.3.1 CBR Systems Inc.
16.3.2 中国臍帯血公司
16.3.3 コードライフ
16.3.4 Cordvida
16.3.5 Cryo-Cell International, Inc.
16.3.6 クライオセーブAG（エスペライトのグループ会社）
16.3.7 クライオビバ・インディア
16.3.8 ライフセル
16.3.9 スマート・セルズ・インターナショナル・リミテッド
16.3.10 ヴィアコード
表1：世界：幹細胞バンキング市場：主要産業ハイライト、2023年および2032年
表2：世界の幹細胞バンキング市場予測：製品タイプ別内訳（単位：百万米ドル）、2024年～2032年
表3：世界の幹細胞バンキング市場予測：サービスタイプ別内訳（単位：百万米ドル）、2024-2032年
表4：世界の幹細胞バンキング市場予測：バンクタイプ別構成比（単位：百万米ドル）、2024-2032年
表5：世界の幹細胞バンキング市場予測：世界：幹細胞バンキング市場予測：利用別内訳（単位：百万米ドル）、2024-2032年
表6：世界の幹細胞バンキング市場予測：用途別構成比（単位：百万米ドル）、2024-2032年
表7：世界の幹細胞バンキング市場予測：地域別内訳（単位：百万米ドル）、2024-2032年
表8：世界の幹細胞バンキング市場構造
表9：世界の幹細胞バンキング市場：主要プレイヤー
図1：世界：幹細胞バンキング市場：主な推進要因と課題
図2：世界：幹細胞バンキング市場：販売額（単位：億米ドル）、2018年～2023年
図3：世界：幹細胞バンキング市場：製品タイプ別内訳（単位：%）、2023年
図4：世界：幹細胞バンキング市場：サービスタイプ別構成比（%）、2023年
図5：世界の幹細胞バンキング市場：サービスタイプ別構成比（単位：%）、2023年図5：幹細胞バンキングの世界市場：バンクタイプ別構成比（%）、2023年
図6：世界：幹細胞バンキング市場：世界の幹細胞バンキング市場：利用率別構成比（%）、2023年
図7：世界の幹細胞バンキング市場：用途別構成比（%）、2023年世界：幹細胞バンキング市場：用途別構成比（%）、2023年
図8：世界の幹細胞バンキング市場：用途別構成比（%）、2023年図8：世界の幹細胞バンキング市場：地域別構成比（%）、2023年
図9：世界の幹細胞バンキング市場予測：販売額（単位：億米ドル）、2024年～2032年
図10：世界の幹細胞バンキング産業：SWOT分析
図11: 世界：幹細胞バンキング産業：バリューチェーン分析
図12: 世界：幹細胞バンキング産業：ポーターのファイブフォース分析
図13：世界：幹細胞バンキング（成人幹細胞）市場：販売額（単位：百万米ドル）、2018年および2023年
図14：世界：幹細胞バンキング（成人幹細胞）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図15：世界の幹細胞バンキング（ヒト胚細胞）市場：販売額（単位：百万米ドル）、2018年・2023年
図16：世界の幹細胞バンキング（ヒト胚性細胞）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図17：世界の幹細胞バンキング（IPS細胞）市場：販売額（単位：百万米ドル）、2018年・2023年
図18：世界の幹細胞バンキング（IPS細胞）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図19：世界の幹細胞バンキング（サンプル保存・保管）市場：販売額（単位：百万米ドル）、2018年・2023年
図20：世界の幹細胞バンキング（サンプル保存・保管）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図21：世界の幹細胞バンキング（サンプル分析）市場：販売額（単位：百万USドル）、2018年・2023年
図22：世界の幹細胞バンキング（サンプル分析）市場予測：販売額（単位：百万USドル）、2024年～2032年
図23：世界の幹細胞バンキング（サンプル処理）市場：販売額（単位：百万USドル）、2018年・2023年
図24：世界の幹細胞バンキング（サンプル処理）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図25：世界：幹細胞バンキング（サンプル採取・輸送）市場：販売額（単位：百万米ドル）、2018年・2023年
図26：世界：幹細胞バンキング（サンプル採取・輸送）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図27：世界：幹細胞バンキング（民間）市場：販売額（単位：百万米ドル）、2018年および2023年
図28：世界：幹細胞バンキング（民間）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図29：世界：幹細胞バンキング（公的）市場：販売額（単位：百万米ドル）、2018年および2023年
図30：世界：幹細胞バンキング（公共）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図31：世界：幹細胞バンキング（中古）市場：販売額（単位：百万米ドル）、2018年および2023年
図32：世界：幹細胞バンキング（中古）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図33：世界：幹細胞バンキング（未使用）市場：販売額（単位：百万米ドル）、2018年および2023年
図34：世界：幹細胞バンキング（未使用）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図35：世界：幹細胞バンキング（個別化バンキング用途）市場：販売額（単位：百万米ドル）、2018年・2023年
図36：世界：幹細胞バンキング（個別化バンキング用途）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図37：世界：幹細胞バンキング（研究用途）市場：販売額（単位：百万米ドル）、2018年および2023年
図38：世界：幹細胞バンキング（研究用途）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図39：世界：幹細胞バンキング（臨床用途）市場：販売額（単位：百万米ドル）、2018年および2023年
図40：世界：幹細胞バンキング（臨床用途）市場予測：販売額（単位：百万米ドル）、2024年～2032年
図41：北米：幹細胞バンキング市場：販売額（単位：百万米ドル）、2018年および2023年
図42：北米：幹細胞バンキング市場予測：販売額（単位：百万米ドル）、2024年～2032年
図43：ヨーロッパ：幹細胞バンキング市場：販売額（単位：百万米ドル）、2018年および2023年
図44：欧州：幹細胞バンキング市場予測：販売額（単位：百万米ドル）、2024年～2032年
図45：アジア太平洋地域：幹細胞バンキング市場：販売額（単位：百万米ドル）、2018年および2023年
図46：アジア太平洋地域：幹細胞バンキング市場予測：販売額（単位：百万米ドル）、2024年～2032年
図47：中東およびアフリカ：幹細胞バンキング市場：販売額（単位：百万米ドル）、2018年および2023年
図48：中東およびアフリカ：幹細胞バンキング市場予測：販売額（単位：百万米ドル）、2024年～2032年
図49：ラテンアメリカ：幹細胞バンキング市場：販売額（単位：百万米ドル）、2018年および2023年
図50：ラテンアメリカ：幹細胞バンキング市場予測：販売額（単位：百万米ドル）、2024年～2032年
The global stem cell banking market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing improvements in stem cell isolation, storage, and transportation technologies, the rising healthcare expenditure, the growing progress in regenerative medicine, and the heavy investments by private companies are some of the factors propelling the market.
Stem cell banking, a revolutionary medical advancement, offers a lifeline for the future. This process involves preserving stem cells from various sources, such as umbilical cord blood or adult tissues. These cells possess remarkable regenerative potential, holding the key to treating multiple diseases, from leukemia to neurodegenerative conditions like Parkinson's. Stem cell banking safeguards these biological treasures by cryogenically freezing them at ultra-low temperatures, ensuring their viability for decades. The implications are profound. Families can secure a biological insurance policy, as these cells can treat the donor and genetically compatible relatives, reducing the risk of immune rejection. Additionally, stem cell research continues to unveil new therapeutic applications, promising breakthroughs in personalized medicine. However, accessibility remains an issue, with costs and awareness varying globally. Stem cell banking is a visionary investment in health. It can unlock a future where debilitating diseases are treated with the patient's cells, eliminating the need for risky transplants and opening new frontiers in medical science. Expanding access and awareness of this transformative technology is essential to harness its full potential for the benefit of humanity.
The global market is majorly driven by increasing awareness of the therapeutic potential of stem cells in treating a wide array of diseases, including cancer, diabetes, and cardiovascular conditions. This heightened awareness is fueled by extensive research and clinical trials that continually demonstrate the efficacy of stem cell-based therapies, capturing the imagination of medical professionals and the general public. Furthermore, the expanding trend of delayed parenthood, with more couples opting to have children later in life, has intensified interest in umbilical cord blood banking. Parents recognize the value of preserving their newborn's cord blood stem cells as biological insurance should their child or a family member face a future medical challenge. Moreover, the globalization of stem cell banking services is another key driver. Advances in cryopreservation techniques have extended the shelf life of stored stem cells, allowing for international transportation and cross-border utilization. This has widened the market's reach and fostered worldwide collaboration among stem cell banks. Additionally, government support and regulatory frameworks are becoming more conducive to stem cell banking, fostering a favorable environment for investment and growth. The increasing prevalence of chronic diseases and the potential of stem cells to provide personalized treatments solidifies its position as a pivotal component of future healthcare, ensuring the market's continued expansion.
Stem Cell Banking Market Trends/Drivers:
Increasing aging population
The increasing aging population is positively influencing the market. This demographic shift is transforming healthcare dynamics globally. As individuals age, they become more susceptible to degenerative diseases such as Osteoarthritis, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's and Parkinson's. Stem cells hold immense promise in regenerating damaged or aging tissues, offering the potential for groundbreaking treatments and enhanced quality of life for older people. This growing elderly population demands more advanced healthcare solutions and represents a substantial customer base for stem cell banking services. Several individuals and families recognize the potential of preserving their or their loved ones' stem cells, harvested from sources like cord blood or adipose tissue. These stored stem cells can be used in future therapies to combat age-related health issues, creating a sense of security and optimism. As a result, the aging population's increasing awareness of the regenerative potential of stem cells, coupled with their desire for improved healthcare options, is a driving force behind the rising demand for stem cell banking services, positioning the market for sustained growth in the years to come.
Rising acceptance of clinical trials
The rising acceptance of clinical trials is catalyzing the market. Clinical trials are pivotal in demonstrating the safety and efficacy of stem cell-based therapies across various medical conditions, ranging from cancer to spinal cord injuries. As the results of these trials continue to show promise, confidence in stem cell-based treatments is bolstered among medical professionals, researchers, and the general public. This increasing acceptance translates into greater demand for stem cell banking services. Clinical trials often require a readily accessible and reliable source of high-quality stem cells, and banks specializing in storing these cells meet this critical need. Researchers and pharmaceutical companies rely on these banks to provide the standardized and well-preserved stem cell samples required for their trials, thus driving the market's growth. Furthermore, positive outcomes from clinical trials advance the regenerative medicine field and attract investments from both the public and private sectors, fostering innovation and expanding the range of stem cell banking services available. This virtuous cycle of research, acceptance, and investment propels the market.
Escalating ethical concerns surrounding the use of embryonic stem cells
The escalating ethical concerns surrounding the use of embryonic stem cells are bolstering the market. Embryonic stem cell research has long been a subject of ethical debate due to destroying embryos, resulting in moral and regulatory restrictions in many regions. This has shifted the focus of stem cell research and therapeutic applications towards non-controversial sources, such as adult stem cells and cord blood. As a result, individuals and institutions seeking the potential benefits of stem cell therapies without ethical quandaries are turning to stem cell banking. Cord blood, in particular, has gained prominence as a rich source of stem cells without any ethical concerns. Families and healthcare providers recognize the value of preserving these cells as biological insurance against future illnesses for the donor and potentially compatible family members. This shift towards ethically sound stem cell sources aligns with the practices of most stem cell banks, attracting a broader customer base and contributing to the industry's growth. The market is well-positioned for sustained expansion as ethical considerations continue influencing public opinion and regulatory decisions.
Stem Cell Banking Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, service type, bank type, utilization and application.
Breakup by Product Type:
Adult Stem Cells
Human Embryonic Cells
IPS Cells
Adult stem cells dominate the market
The report has provided a detailed breakup and analysis of the market based on the product type. This includes adult stem cells, human embryonic cells, and IPS cells. According to the report, adult stem cells represented the largest segment.
Adult stem cells, also known as somatic or tissue-specific, have emerged as a game-changer in regenerative medicine. These cells are ethically uncontroversial, sourced from bone marrow, adipose tissue, and peripheral blood. Their therapeutic potential in treating various ailments, including orthopedic issues, cardiovascular diseases, and autoimmune disorders, is increasingly recognized.
The rising demand for adult stem cell banking services stems from the growing awareness of their versatility and effectiveness. Patients, physicians, and researchers are considering preserving adult stem cells as a proactive approach to future medical challenges. This demand drives competition and innovation within the industry, resulting in improved storage techniques and expanded service offerings. As regenerative medicine continues to advance, the adult stem cell segment stands as a linchpin in the market's overall expansion, promising personalized healthcare solutions for various conditions and securing its position at the forefront of medical progress.
Breakup by Service Type:
Sample Preservation and Storage
Sample Analysis
Sample Processing
Sample Collection and Transportation
Sample preservation and storage dominate the market
The report has provided a detailed breakup and analysis of the market based on the service type. This includes sample preservation and storage, sample analysis, sample processing, and sample collection and transportation. According to the report, sample preservation and storage represented the largest segment.
Sample preservation and storage segment plays a pivotal role in propelling the market. Stem cell therapies have emerged as a revolutionary medical frontier, promising treatments for various diseases and conditions. Consequently, the demand for safe and reliable storage solutions for precious stem cell samples has skyrocketed. These services offered by stem cell banks ensure these valuable biological assets' long-term viability and potency. This crucial service segment encompasses cutting-edge cryopreservation techniques, state-of-the-art storage facilities, and rigorous quality control measures.
In an era where regenerative medicine is gaining prominence, the efficacy of stem cell treatments hinges on the integrity and accessibility of stored samples. The commitment of stem cell banks to maintaining optimal sample conditions instills confidence in healthcare providers and encourages individuals to invest in stem cell banking for their future medical needs. This rising demand for Sample Preservation and Storage services drives the revenue growth of stem cell banks and fuels advancements in biotechnology and medical research, ultimately paving the way for innovative therapies and improved healthcare outcomes.
Breakup by Bank Type:
Private
Public
Private dominates the market
The report has provided a detailed breakup and analysis of the market based on the bank type. This includes private and public. According to the report, private represented the largest segment.
Private stem cell banks cater to the growing trend of individuals and families taking proactive measures to secure their health and that of their loved ones. These banks offer a unique opportunity for clients to preserve their own or their newborn's stem cells, often sourced from cord blood, for potential future medical needs. This personalized approach to healthcare resonates strongly with a wide demographic, ranging from expectant parents seeking to secure their child's health to adults considering their long-term well-being.
The appeal of private stem cell banks lies in the assurance of access and control over one's biological assets a sense of biological insurance. As medical research unveils novel therapies and applications for stem cells, private banks' convenience and peace of mind are significant drivers of market growth. This segment's emphasis on personalized healthcare aligns with the evolving healthcare landscape, cementing its role in shaping the future of medicine and propelling market growth.
Breakup by Utilization:
Used
Unused
Unused dominates the market
The report has provided a detailed breakup and analysis of the market based on the utilization. This includes used and unused. According to the report, unused represented the largest segment.
The unused segment is equally influential, especially with the growing trend toward proactive healthcare. Individuals and families recognize the intrinsic value of preserving stem cells for potential future use, even without immediate medical need. This preventive approach is reinforced by ongoing research revealing new applications for stem cells. The prospect of securing biological insurance against unforeseen health challenges or benefiting from emerging therapies amplifies the demand for stem cell banking services, further solidifying its position as a dynamic force in modern healthcare.
Furthermore, the used segment reflects the escalating clinical adoption of stem cell-based therapies and treatments, spanning various medical conditions from leukemia to spinal cord injuries. As the effectiveness and safety of these therapies become increasingly established through clinical trials and real-world applications, the demand for access to stored stem cell samples surges. This drives the growth of stem cell banking services as patients and healthcare providers seek reliable sources for viable and high-quality stem cells.
Breakup by Application:
Personalized Banking Applications
Research Applications
Clinical Applications
Clinical applications dominate the market
The report has provided a detailed breakup and analysis of the market based on the application. This includes personalized banking applications, research applications, and clinical applications. According to the report, clinical applications represented the largest segment.
Stem cells hold immense potential in regenerative medicine, and clinical applications harness this potential to treat various medical conditions. From neurological disorders like Parkinson's and Alzheimer's to orthopedic injuries and autoimmune diseases, stem cell-based therapies offer new hope for patients worldwide. The availability of well-preserved and diverse stem cell samples from banks is paramount for successful clinical interventions.
Clinical applications encompass established treatments and cutting-edge therapies in various stages of development, including clinical trials. These applications demand various stem cell types, such as hematopoietic, mesenchymal, and induced pluripotent stem cells, each tailored to specific medical needs. Stem cell banks offering a comprehensive array of these resources contribute significantly to the growth of clinical applications in regenerative medicine.
Furthermore, as research expands our understanding of stem cell biology and therapeutic potential, the clinical landscape is poised for continuous evolution. Consequently, the Clinical Applications segment remains a key driver in the stem cell banking market, fostering innovation and offering renewed optimism for patients seeking novel treatments and improved healthcare outcomes.
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America exhibits a clear dominance, accounting for the largest market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.
North America plays a pivotal role in driving the growth of the market. With its advanced healthcare infrastructure, robust research and development activities, and a population increasingly aware of the potential benefits of stem cell therapies, the region stands at the forefront of this burgeoning industry. In the region, stem cell banking is viewed as a proactive health measure and a source of hope for patients suffering from a range of debilitating conditions.
In particular, the United States and Canada have witnessed significant investments in private stem cell banks driven by a combination of healthcare advancements and a culture of health-consciousness. Furthermore, the region's regulatory environment has been relatively supportive, further bolstering market growth by fostering a favorable climate for stem cell banking services.
As clinical trials for stem cell-based therapies expand, and research endeavors continue to flourish in North America, the demand for high-quality stem cell preservation and banking services continues to rise, making this region a powerhouse in shaping the future of stem cell banking.
Competitive Landscape:
Top companies are pivotal in strengthening market growth through a multifaceted approach. These industry leaders invest heavily in cutting-edge research and development, driving innovation in stem cell preservation and analysis techniques. They continually enhance the quality and viability of stored stem cells, instilling confidence in their clients and the medical community. These companies also prioritize extensive collaborations with research institutions, pharmaceutical firms, and healthcare providers. This collaborative spirit fosters the advancement of stem cell-based therapies, expanding their applications and creating a growing demand for banking services. Moreover, top firms actively engage in public awareness campaigns, educating individuals and families about the potential benefits of stem cell banking. This outreach grows the customer base and fuels interest in stem cell research and regenerative medicine. Additionally, their international presence and ability to provide cross-border services amplify market reach and accessibility, further driving growth.
The report has provided a comprehensive analysis of the competitive landscape in the stem cell banking market. Detailed profiles of all major companies have also been provided.
CBR Systems Inc.
China Cord Blood Corporation
Cordlife
Cordvida
Cryo-Cell International, Inc.
Cryo-Save AG (A Group of Esperite)
Cryoviva India
Lifecell
Smart Cells International Ltd
Viacord
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent Developments:
In July 2023, Cordlife announced advanced research on Mesenchymal Stem Cell Secretome-based products for treating Osteoarthritis.
In March 2022, Cryo-Cell International, Inc. revealed its acquisition of a 56,000-square-foot facility in the Research Triangle, North Carolina, within the Regional Commerce Center. This acquisition is contingent upon the fulfillment of standard closing conditions.
Key Questions Answered in This Report
1. What was the size of the global stem cell banking market in 2023?
2. What is the expected growth rate of the global stem cell banking market during 2024-2032?
3. What are the key factors driving the global stem cell banking market?
4. What has been the impact of COVID-19 on the global stem cell banking market?
5. What is the breakup of the global stem cell banking market based on the product type?
6. What is the breakup of the global stem cell banking market based on the service type?
7. What is the breakup of the global stem cell banking market based on the bank type?
8. What is the breakup of the global stem cell banking market based on the utilization?
9. What is the breakup of the global stem cell banking market based on the application?
10. What are the key regions in the global stem cell banking market?
11. Who are the key players/companies in the global stem cell banking market?
